Skip to main content
OpenTrials
Completed

NCT Number: NCT04746014

Clearblue Pregnancy Test Lay User Usage Study

The Clearblue home pregnancy test (HPT) is an over the counter urine hCG (human chorionic gonadotrophin) visual pregnancy test which is intended for the detection of pregnancy. This study will assess the performance of the HPT in the hands of the lay user by comparing their results when used according to the instructions for use (IFU) to (i) confirmed pregnancy status of the volunteers and (ii) to the results of trained study staff testing the same urine samples.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

WCCT

Cypress, California, 90630, United States

About this study

The Clearblue HPT is an over the counter urine hCG visual-read test which is intended for the detection of pregnancy. This study aims to demonstrate that the pregnancy test has the required performance characteristics in lay user testing. The study will recruit a cross-section of the target pregnancy test user population, that is, women aged over 18 years representative of the intended user.

A minimum of 300 women will be required to complete the study consisting of both pregnant and not pregnant volunteers. Each volunteer will conduct the pregnancy test using their preferred sampling method (either 'in-stream' or 'dip'). Volunteers will be evaluated against confirmed pregnancy status. Lay user comprehension of the device instructions and usability of the device will also be assessed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Aged 18 and over
  • Interested in conducting a personal pregnancy test to determine or confirm their pregnancy status
  • Willing to reveal their pregnancy status
  • Willing to provide a blood sample
  • Willing to give informed consent

Exclusion criteria

  • Significant affiliation with SPD
  • Used the investigational pregnancy test previously
  • Qualified or trainee healthcare professional (HCP)
  • Has professional experience (in current or previous job) of using dipstick type tests or lateral flow devices
  • Confirmed to be pregnant by a healthcare professional and beyond the first trimester (defined as last menstrual period (LMP) +13 weeks)
  • Has a medical condition that means that it is not appropriate to give a blood sample

Treatment and study plan

Clearblue Pregnancy Test

Diagnostic Test

Urine Pregnancy Test

Primary outcomes

  1. Accuracy of Clearblue Pregnancy Test

    Time frame: 3 days

    Number of pregnancy tests in agreement with pregnancy status

Secondary outcomes

  1. Co-ordinator Agreement

    Time frame: 1 day

    Number of lay users who record the same pregnancy test result as a trained study co-ordinator

  2. Comprehension of Instructions for Use

    Time frame: 1 day

    Number of volunteers who answer each comprehension question correctly

  3. Device Usability

    Time frame: 1 day

    Number of volunteers who record the device as easy to use

Sponsors and collaborators

Lead sponsor

SPD Development Company Limited

Industry

Collaborators

  • WCCT Global

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Feb 9, 2021
Registry last updated
Aug 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.